Home Medicine Treatment of severe postpartum hemorrhage by rectally administered gemeprost pessaries
Article
Licensed
Unlicensed Requires Authentication

Treatment of severe postpartum hemorrhage by rectally administered gemeprost pessaries

  • S. Craig , H. Chau and H. Cho
Published/Copyright: June 1, 2005
Journal of Perinatal Medicine
From the journal Volume 27 Issue 3

Abstract

Objective. To assess the efficacy of rectally administered gemeprost pessaries in the tretament of severe postpartum hemorrhage.

Design. Retrospective analysis of a twelve month period in which all patients having postpartum hemorrhage treated with rectal gemeprost were analyzed.

Setting. Royal Darwin Hospital, Northern Territory, Australia.

Population. Fourteen women with established postpartum hemorrhage not responding to oxytocine and ergo-metrine regimens, or not responsive to oxytocine and having contraindications to ergometrine.

Main outcome measures. Per vaginum bleeding with continued postpartum hemorrhage; adverse patient reactions to gemeprost; need for operative intervention.

Results. All patients who were treated with rectally administered gemeprost pessaries had cessation of bleeding per vaginum. There were no adverse side effects noted from the medication and no patient required surgical treatment.

Conclusions. Rectally administered gemeprost administered pessaries appear to be safe and effective method of treating severe postpartum hemorrhage in those patients in whom the standard oxytocic regimens fail. This form of treatment may avoid the need for parenteral prostaglandins or surgical intervention.

:
Published Online: 2005-06-01
Published in Print: 1999-07-01

Copyright (c)1999 by Walter de Gruyter GmbH & Co. KG

Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.1999.033/html
Scroll to top button